Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...

ONE GRAND PRIX THIS WEEKEND. FIVE ON YOUR HEALTH TONIGHT. SEVERE SIDE EFFECTS FROM SEMAGLUTIDE, A NATIONAL STUDY FINDS THEY SENT NEARLY 25,000 PEOPLE TO THE ER FOR TREATMENT. JOINING US NOW IS DOCTOR ...

Reproductive symptoms, temperature-related complaints, and psychiatric symptoms are among the side effects of GLP-1s reported ...

A groundbreaking study has identified some of the most frequently reported side effects of weight loss injections. Research found that almost half of participants using GLP-1 inhibitors were ...

Researchers conducted a phase 3 trial to compare the efficacy and safety of synthetic semaglutide with Ozempic® for glycemic ...

Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...

Wegovy (semaglutide) and Zepbound (tirzepatide) are commonly prescribed medications for weight management. Semaglutide, the ...

Compounded medications are not FDA-approved. This means they haven’t undergone the same rigorous testing for safety and effectiveness. The FDA advises against using compounded versions unless approved ...

Yale Medicine specialists explain how new oral forms of GLP-1 obesity medications work, how effective they are, and what to ...